CAS 1012343-93-9

Formel: C21H21N5O4S

InChl: InChI=1S/C21H21N5O4S/c1-29-18-8-5-15(11-19(18)30-2)17-13-24-21-10-9-20(25-26(17)21)23-12-14-3-6-16(7-4-14)31(22,27)28/h3-11,13H,12H2,1-2H3,(H,23,25)(H2,22,27,28)

InChI Key: UPFVAHVWLNBVSG-UHFFFAOYSA-N

SMILES: COC1=C(C=C(C=C1)C2=CN=C3N2N=C(C=C3)NCC4=CC=C(C=C4)S(=O)(=O)N)OC

Irak inhibitor 3

CAS: 1012343-93-9

Irak inhibitor 3

Formel: C₂₁H₂₁N₅O₄S

Reinheit: ≥95%

Molekulargewicht: 439.49

Ref: 54-OR1106853

IRAK inhibitor 3

CAS: 1012343-93-9

IRAK inhibitor 3

Formel: C₂₁H₂₁N₅O₄S

Reinheit: 98.5%

Molekulargewicht: 439.49

Ref: 54-BUP20555

IRAK inhibitor 3

CAS: 1012343-93-9

Formel: C₂₁H₂₁N₅O₄S

Reinheit: 98.17%

Molekulargewicht: 439.4875

Ref: IN-DA008TGZ

IRAK inhibitor 3

CAS: 1012343-93-9

IRAK inhibitor 3 is a prodrug that is converted to the active form by enzymes in the body. This drug has been shown to be effective against colitis, mediated cancer therapy, and bowel disease. IRAK inhibitor 3 also has antitumour activity and inhibits inflammation in an animal model of inflammatory bowel disease. The structural formula of IRAK inhibitor 3 is shown below: IRAK Inhibitor 3

Formel: C₂₁H₂₁N₅O₄S

Reinheit: Min. 95%

Molekulargewicht: 439.49 g/mol

Ref: 3D-MQB34393

IRAK inhibitor 3

CAS: 1012343-93-9

IRAK inhibitor 3 is an interleukin-1 (IL-1) receptor-associated kinase (IRAK) modulator.

Formel: C₂₁H₂₁N₅O₄S

Reinheit: 98.86%

Farbe und Form: Solid

Molekulargewicht: 439.488

Ref: TM-T11670